Journals / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 1

A case report on bullous cellulitis due to Roseomonas gilardii infection

Pages
117–119
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

She fully recovered in two weeks.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bullous cellulitis is most often caused by beta-hemolytic streptococci and rarely by other bacteria such as Roseomonas gilardii.
📊
Key Findings & Data:We described a case of a 75-year-old female who acquired bullous cellulitis secondary to R. gilardii bacteremia.
💡
Conclusion & Impact:She fully recovered in two weeks.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bullous cellulitis is most often caused by beta-hemolytic streptococci and rarely by other bacteria such as Roseomonas gilardii. We described a case of a 75-year-old female who acquired bullous cellulitis secondary to R. gilardii bacteremia. She presented with multiple, raised skin lesions all over her body. She was afebrile. Her physical examination revealed leucocytosis predominant granulocytes count. She also had anemia (9.4 g/dL) and raised C-reactive protein. During admission, she was treated with intravenous ampicillin/sulbactam and subsequently changed to oral ciprofloxacin following discharge. She fully recovered in two weeks.

🔖

Cite This Article

AZMI, N. L., JEFFERY, E. N. A. A. W. (2022). A case report on bullous cellulitis due to Roseomonas gilardii infection. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 1, 117–119. https://ajindex.com/articles/526752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Muhart M, Helfman T, Kerdel F. Successful use of intravenous steroids and pentoxifylline in the treatment of bullous hemorrhagic cellulitis. J Dermatolog Treat. 1996;7:193-194
  2. Salabei JK, Fishman TJ, Marachi A, Lopez VM, Bazikian Y, Calestino M. Bullous cellulitis caused by Pseudomonas putida in a patient with end-stage renal disease. IDCases. 2020;20:e00735
  3. Shokar NK, Shokar GS, Islam J, Cass AR. Roseomonas gilardii infection: Case report and review. J Clin Microbiol. 2002;40:4789-4791
  4. Kaore NM, Khan Z, Aher AR, Ramnani VK. Community acquired Roseomonas infection in a pre-existing Tubercular lung lesion. Lung India. 2014;31:289-292
  5. Dé I, Rolston KVI, Han XY. Clinical significance of Roseomonas species isolated from catheter and blood samples: Analysis of 36 cases in patients with cancer. Clin Infect Dis. 2004;38:1579- 1584
  6. Vasallo FJ, Alcalá L, Cercenado E, García-Garrote F, Rodríguez-Créixems M, Bouza E. Bacteremia due to Roseomonas spp. Clin Microbiol Infect. 1998;4:109-112
  7. Lewis L, Stock F, Williams D, M MTA, Weir S, Gill VEEJ. Infections with Roseomonas gilardii and review of characteristics used for biochemical identification and molecular typing. Microbiol Infect Dis. 1996;108:210-216
  8. Kim YK, Moon JS, Song KE, Lee WK. Two cases of bacteremia due to Roseomonas mucosa. Ann Lab Med. 2016;36:367-370
  9. Mulita F, Oikonomou N, Provatidis A, Alexopoulos A, Maroulis I. Roseomonas gilardii in patient with leukemia and acute appendicitis: Case report and review. Pan Afr Med J. 2020;36:283
  10. Shao S, Guo X, Guo P, Cui Y, Chen Y. Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature. BMC Infect Dis. 2019;19:140
  11. Tsai SF, Chen CH, Shu KH, Wu MJ. Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: Case report and literature review. Intern Med. 2012;51:1721-1724
  12. Kimura K, Hagiya H, Nishi I, Yoshida H, Tomono K. Roseomonas mucosa bacteremia in a neutropenic child: A case report and literature review. IDCases. 2018;14:e00469.